Completed PHASE4 INTERVENTIONAL 2-arm NCT04726098

Low or High Dose of Dexamethasone in Patients With Respiratory Failure by COVID-19 (HIGHLOWDEXA)

Efficacy of Low or High Dose of Dexamethasone in Patients With Respiratory Failure by COVID-19

Sponsor: Manuel Taboada Muñiz

Interventions Dexamethasone high dose Dexamethasone low dose

Updated 4 times since 2021 Last updated: Oct 19, 2021 Started: Jan 15, 2021 Primary completion: Aug 31, 2021 Completion: Aug 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Corticosteroids and Covid19 and is currently completed. Manuel Taboada Muñiz leads this study, which shows 4 recorded versions since 2021 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Nov 2021 — Jul 2024 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Feb 2021 — Nov 2021 [monthly]

Recruiting PHASE4

First recorded

Jan 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Manuel Taboada Muñiz

Data source: Hospital Clinico Universitario de Santiago

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Santiago de Compostela, Spain